Cost-effectiveness analysis of short-duration dual antiplatelet therapy with newer drug-eluting stent platforms versus longer-duration dual antiplatelet therapy with a second-generation drug-eluting stent in elective percutaneous coronary intervention.
Galper, Benjamin Z, Matthew R Reynolds, Pallav Garg, Eric A Secemsky, Linda R Valsdottir, David J Cohen, and Robert W Yeh. 2019. “Cost-Effectiveness Analysis of Short-Duration Dual Antiplatelet Therapy With Newer Drug-Eluting Stent Platforms versus Longer-Duration Dual Antiplatelet Therapy With a Second-Generation Drug-Eluting Stent in Elective Percutaneous Coronary Intervention.”. Coronary Artery Disease 30 (3): 177-82.